Literature DB >> 2036352

Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.

N P Jones1, R J Postlethwaite, J L Noble.   

Abstract

A 2-year-old girl with nephropathic cystinosis was successfully treated with topical cysteamine 0.5% to one eye. Clearance of crystals from the treated cornea was virtually complete after three months. The possibilities and limitations of this form of treatment are discussed.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2036352      PMCID： PMC1042364          DOI： 10.1136/bjo.75.5.311

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  10 in total

1.  Recurrent crystal deposition after keratoplasty in nephropathic cystinosis.

Authors:  B Katz; R B Melles; J A Schneider
Journal:  Am J Ophthalmol       Date:  1987-08-15       Impact factor: 5.258

2.  Corneal transplant in boy with nephropathic cystinosis.

Authors:  M I Kaiser-Kupfer; M B Datiles; W A Gahl
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

3.  A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis.

Authors:  M I Kaiser-Kupfer; M A Gazzo; M B Datiles; R C Caruso; E M Kuehl; W A Gahl
Journal:  Arch Ophthalmol       Date:  1990-05

4.  Cysteamine therapy for children with nephropathic cystinosis.

Authors:  W A Gahl; G F Reed; J G Thoene; J D Schulman; W B Rizzo; A J Jonas; D W Denman; J J Schlesselman; B J Corden; J A Schneider
Journal:  N Engl J Med       Date:  1987-04-16       Impact factor: 91.245

5.  Glare disability in nephropathic cystinosis.

Authors:  B Katz; R B Melles; J A Schneider
Journal:  Arch Ophthalmol       Date:  1987-12

6.  Spatial and temporal sequence of corneal crystal deposition in nephropathic cystinosis.

Authors:  R B Melles; J A Schneider; N A Rao; B Katz
Journal:  Am J Ophthalmol       Date:  1987-12-15       Impact factor: 5.258

7.  Cysteamine induces cataracts in newborn rats.

Authors:  T Truong; S M Sagar; W J Millard; J L Shaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-10       Impact factor: 4.799

8.  Range of toxicity of topical cysteamine in rabbit eyes.

Authors:  S Jain; T Kuwabara; W A Gahl; M I Kaiser-Kupfer
Journal:  J Ocul Pharmacol       Date:  1988

9.  Long-term ocular manifestations in nephropathic cystinosis.

Authors:  M I Kaiser-Kupfer; R C Caruso; D S Minkler; W A Gahl
Journal:  Arch Ophthalmol       Date:  1986-05

10.  Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.

Authors:  M I Kaiser-Kupfer; L Fujikawa; T Kuwabara; S Jain; W A Gahl
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245
  10 in total
  9 in total

1.  Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.

Authors:  Jennifer L Simpson; Chyong Jy Nien; Kevin J Flynn; James V Jester
Journal:  Mol Vis       Date:  2011-10-08       Impact factor: 2.367

Review 2.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.

Authors:  Ekaterini Tsilou; Min Zhou; William Gahl; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

3.  Quantitative in vivo and ex vivo confocal microscopy analysis of corneal cystine crystals in the Ctns knockout mouse.

Authors:  Jennifer Simpson; Chyong Jy Nien; Kevin Flynn; Brian Jester; Stephanie Cherqui; James Jester
Journal:  Mol Vis       Date:  2011-08-17       Impact factor: 2.367

Review 4.  Treatment of corneal cystine crystal accumulation in patients with cystinosis.

Authors:  Fatemeh Shams; Iain Livingstone; Dilys Oladiwura; Kanna Ramaesh
Journal:  Clin Ophthalmol       Date:  2014-10-10

Review 5.  Clinical Practice: A Proposed Standardized Ophthalmological Assessment for Patients with Cystinosis.

Authors:  Anne-Marie Pinxten; Minh-Tri Hua; Jennifer Simpson; Katharina Hohenfellner; Elena Levtchenko; Ingele Casteels
Journal:  Ophthalmol Ther       Date:  2017-05-05

6.  The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series.

Authors:  Susmito Biswas; Krishanthy Sornalingam
Journal:  Ophthalmol Ther       Date:  2018-12-05

7.  Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis.

Authors:  Freya Peeters; Catherine Cassiman; Karel Van Keer; Elena Levtchenko; Koenraad Veys; Ingele Casteels
Journal:  Ophthalmol Ther       Date:  2019-09-27

8.  A case of corneal cystinosis in a patient with rickets and chronic renal failure.

Authors:  Jae Yon Won; Hyung Bin Hwang; Sung Kun Chung
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

Review 9.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.

Authors:  Achini K Makuloluwa; Fatemeh Shams
Journal:  Clin Ophthalmol       Date:  2018-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.